The core of our investment strategy is made up of buyouts and loan-to-own debt investments, in which we have invested £1 billion since 2011.
We have a longer track record of investing in buyouts and co-investments going back many years before 2011. We have also invested, both before and since 2011, in portfolios of secondary investments as well as performing credit assets.
Over the past 40 years we, together with our predecessor firms, have invested in excess of £5 billion in over 200 deals. This track record of investing through numerous economic cycles gives us broad and deep experience across sectors, geographies and business models.
In 2013, Epiris invested £103 million to acquire the majority of UBM plc's Data Services businesses.
AXIO originally comprised seven market-leading information businesses providing critical, and often industry-standard, information and tools used by professionals to support their decision-making. Today AXIO comprises two businesses, RISI in the forest products sector and TechInsights in the intellectual property licensing sector.
A robust and cash generative portfolio of companies which offers diversity by virtue of operating across a range of sectors and geographies. The companies have strong brands benefitting from strong customer relationships and hold leadership positions in niche markets.
To transform each business by developing the right long-term strategy and then delivering through strategic focus, operational improvement and growth investment. The intention is to identify strategic buyers for each of the components of the group.
AXIO has made a number of acquisitions, including FOEX Indexes, a Finnish provider of pulp and paper price indices, FlightView, a US provider of real-time flight information, and Chipworks, a global leader in the intellectual property and technology services market.
In December 2014, AXIO completed its first major realisations, disposing of JOC Group, a worldwide provider of business intelligence, data and events for container shipping and logistics professionals, and Breakbulk, the world's leading brand name in specialised logistics intelligence.
In October 2015, AXIO completed its third major realisation selling MIMS, its Asian healthcare information business, to SMS and Mitsui for $250 million. It also refinanced its aviation business, OAG.
In December 2016, AXIO completed its fourth major realisation, the sale of leading European provider of reference drug information for healthcare professionals, Vidal for €100 million.
In February 2017, AXIO finalised its fifth realisation, selling OAG, the global leader in aviation information and intelligence for $215 million.
Following completion of these transactions, AXIO has returned total cash proceeds amounting to more than 3.9x original cost to our clients.